Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Review of Hematology|January 27, 2026
Integrating an updated high-risk multiple myeloma classification into clinical practice and clinical trial epidemiologyMichael Sang Hughes, Suzanne LentzschPresse Medicale (Paris, France : 1983)|December 13, 2024
Primary systemic amyloidosis: A brief overviewMichael Sang Hughes, Suzanne LentzschTherapeutics and Clinical Risk Management|January 2, 2024
Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL AmyloidosisMichael Sang Hughes, Suzanne LentzschPublic Health Reports (Washington, D.C. : 1974)|December 10, 2020
Electronic Health Record Reminders for Chlamydia Screening in an American Indian PopulationMichael Sang Hughes, Andria Apostolou, Brigg Reilley, et al.European Journal of Haematology|February 5, 2025
Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific AntibodyDivaya Bhutani, Rajshekhar Chakraborty, Karan Wats, et al.European Journal of Haematology|February 24, 2025
Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma TherapiesMichael Sang Hughes, Metodi Balev, Jai Radhakrishnan, et al.Bone Marrow Transplantation|December 27, 2025
CAR T-cells in multiple myeloma: the race to the start lineAbdul-Hamid Bazarbachi, Divaya Bhutani, Michael Sang Hughes, et al.American Journal of Hematology|June 20, 2026
Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline TherapySimon Zhen, Sorina Nicoleta Bandelita, Divaya Bhutani, et al.Pageof 1